IMNN
IMNN
NASDAQ · Biotechnology

Imunon Inc

$1.38
-0.03 (-2.13%)
As of Sep 28, 10:41 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +1,692.8% upside
Low Target $16.96
Average Target $24.74
High Target $28.19
Current Price $1.38
Current
$1.38
Target
$24.74
$16.96 $24.74 avg $28.19
Scenario Analysis
Bear Case
$16.96
1,129.0%
Low target
Base Case
$24.74
+1,692.8%
Avg target
Bull Case
$28.19
+1,942.8%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$5.55
-75.1% from high
52-Week Low
$1.30
+6.2% from low
Target vs 52W High
$24.74
+345.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%